This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Cramer's Action Alerts PLUS - See his portfolio and get alerts BEFORE every trade. Learn more NOW!

Pharma Clinical Trial Services: World Market 2013-2023

Figure 6.3 Pharma Clinical Trial Services Market: Revenue Forecasts for Leading Therapeutic Areas, 2011, 2017 & 2023

Figure 6.4 Cancer Clinical Trial Services Submarket Forecast, 2011-2023

Figure 6.5 CNS Disease Clinical Trial Services Submarket Forecast, 2011-2023

Figure 6.6 Cardiovascular Disease Clinical Trial Services Submarket Forecast, 2011-2023

Figure 6.7 Chronic Hepatitis B & C: Global Prevalence by Region, 2012

Figure 6.8 Infectious Disease Clinical Trial Services Submarket Forecast, 2011-2023

Figure 6.9 Metabolic Disease Clinical Trial Services Submarket Forecast, 2011-2023

Figure 7.1 The 3+3 Staging Trial Design

Figure 7.2 Growth in the Biomarker Services Market, 2011, 2016 & 2022

Figure 8.1 World CRO Market by Company, 2011

Figure 8.2 Quintiles: Risk-Sharing Partnerships, 2002-2011

Figure 8.3 Covance: Revenue by Sector, 2007-2011

Figure 8.4 Covance: Revenue by Sector, Q1-Q3 2011-2012

Figure 8.5 PPD: Revenue by Sector, Q1-Q2 2010-2011

Figure 8.6 Parexel International: Revenue by Sector, 2010-2012

Figure 8.7 Parexel International: Revenue by Region, 2012

Figure 8.8 ICON: Revenue by Sector, 2010-2011

Figure 8.9 ICON: Revenue by Region, 2011

Figure 8.10 Kendle: Net Service Revenue by Sector, 2010

Figure 8.11 inVentiv Health: Revenue by Sector, Q2 2010 & Q2 2011

Figure 8.12 CMIC: CRO Revenue, 2008-2012

Figure 8.13 Chiltern International's Clinical Trials: Therapeutic Experience

Figure 8.14 Chiltern International: Revenue, 2008-2010

Figure 10.1 Pharma Clinical Trial Services Market by Sector, 2011, 2017 & 2023

Companies Listed

3C Alliance

Agência Nacional de Vigilância Sanitária (ANVISA) [ Brazil]

Agility Clinical

Allscripts

Amgen

Aptuit

ASAN Medical Center

Associação Brasileira de CROs (Abracro)

Association for the Accreditation of Human Research Protection Programs (AAHRPP)

Association of Clinical Trial Organisations (ACTO) [ Russia]

Astellas Pharma

Avista Capital Partners

Bayer

BeijingWits Medical Consulting (part of ICON)

Berry Consultants

BioClinica

BioDuro (part of PPD)

BioDuro Biologics

BioTrak

BML

Boehringer Ingelheim

Bristol- Myers Squibb

Caprion Proteomics

11 of 13

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,132.70 -81.72 -0.45%
S&P 500 2,104.50 -6.24 -0.30%
NASDAQ 4,963.5270 -24.3630 -0.49%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs